DBC1通过调控Nrf2乙酰化修饰介导类风湿关节炎成纤维样滑膜细胞铁死亡抵抗的机制研究
批准号:
82101899
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
刘岩
依托单位:
学科分类:
自身免疫性疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
刘岩
中文摘要
成纤维样滑膜细胞(FLS)是类风湿关节炎(RA)中侵袭破坏软骨和骨的主要效应细胞。申请者前期已有研究报道,FLS过度增殖和凋亡抵抗在RA发病中至关重要。然而,其他程序性死亡在RA-FLS中的作用尚不明确。我们在近期实验中发现,RA-FLS存在铁死亡抵抗,且与抗氧化因子Nrf2的活化以及细胞周期凋亡相关基因DBC1的过表达有关。进一步实验表明,敲低DBC1可抑制Nrf2的核内定位和蛋白表达、下调下游铁死亡相关基因的转录,但不影响Nrf2的mRNA水平。DBC1是去乙酰化酶SIRT1的重要调控因子。据此我们推测,DBC1过表达可能通过调控Nrf2乙酰化修饰介导RA-FLS铁死亡抵抗。本项目拟通过临床标本、细胞模型、DBC1基因敲除小鼠和胶原诱导型关节炎小鼠,结合体内外功能实验、蛋白互作实验,进一步阐明RA-FLS铁死亡抵抗的具体机制,为RA治疗提供新靶点、新思路。
英文摘要
Fibroblast-like synoviocytes (FLS) are the main effector cells that invade and destroy cartilage and bone in rheumatoid arthritis (RA). The applicant has reported that hyperproliferation and anti-apoptosis of FLS play crucial rules in the pathogenesis of RA. However, the functions of other programmed cell death in RA-FLS are not clear. In previous experiments, We found that RA-FLS has ferroptosis resistance, which is related to the activation of antioxidant factor Nrf2 and the overexpression of the cell cycle apoptosis regulating gene DBC1. Further experiments showed that knocking down DBC1 can inhibit the intranuclear localization and expression of Nrf2, and suppress the transcription of downstream ferroptosis-related genes, but do not affect the Nrf2 mRNA level. DBC1 negatively regulates the deacetylase SIRT1. Based on this, we speculate that DBC1 overexpression may mediate RA-FLS ferroptosis resistance by regulating acetylation of Nrf2. This project intends to further clarify the specific mechanism of RA-FLS anti-ferroptosis through clinical specimens, cell models, DBC1 knockout mice and collagen-induced arthritis mice, combined with in vivo and in vitro functional experiments, and protein interaction experiments, providing new targets and new ideas for future treatment.
类风湿关节炎(RA)是以破坏性关节病变为主要特征的自身免疫性疾病,是我国最常见的致残性关节炎之一。本课题组前期研究发现,成纤维样滑膜细胞(FLSs)过度增殖和凋亡抵抗在RA发病中至关重要。然而,其他程序性死亡在RA - FLSs中的作用尚不明确。本项目通过临床标本、细胞模型、DBC1基因敲除小鼠和血清诱导型关节炎小鼠模型,结合体内外功能实验和蛋白互作实验,阐明了RA - FLSs铁死亡抵抗的致病作用及DBC1高表达调控铁死亡抵抗的具体机制。我们发现:①RA病灶铁过载加剧关节炎症和骨质破坏;②关节高铁促进FLSs铁死亡抵抗,促进其过度迁移、侵袭表型;③RA - FLSs中DBC1存在高表达,且此表达异常可诱导细胞的铁死亡抵抗;④DBC1负性调节Sirt1,促进Nrf2乙酰化修饰和入核转录,继而激活抗氧化系统,促进FLSs抵抗铁死亡。我们的研究结果表明,调控DBC1表达可能诱导RA - FLSs的铁死亡结局,从而遏制其增生、侵袭和关节破坏的病理进程,为RA靶向治疗提供新思路。
国内基金
海外基金